Internet-based Affect Focused Psychodynamic Therapy for Neuroticism: a Randomized Controlled Trial
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Internet-based psychodynamic therapy (IPDT).
- Who it may be relevant to
- Registry conditions: Trait Neuroticism. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Sweden
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The purpose of the study is to investigate if internet delivered affect-focused psychodynamic therapy (IPDT) leads to lowered levels of trait neuroticism compared to a wait-list control condition. The target group is adults (18+) who experience mild to moderate symptoms of anxiety and/or depression. The IPDT treatment consists of 8 modules that the participants will work with for 9 weeks, with therapist support. Participants will be recruited in Sweden with nationwide recruitment.
Detailed description
This study is a randomized controlled trial with the aim to investigate if IPDT leads to lowered levels of trait neuroticism. Participants will either be randomized to the treatment which is based on Affect Phobia Therapy or to a wait-list control. Participants will have weekly contact with a therapist who will provide feedback and support.
Primary outcome measure is trait neuroticism (measured on the 24-Item Neuroticism scale of the IPIP-NEO-120). Secondary outcome measures will include measures of anxiety, depression, quality of life, emotion regulation, and defense mechanism adaptiveness. Emotion regulation and short measure of anxiety and depressive symptoms will be collected weekly throughout the treatment period. Pre-treatment measurement, post-treatment measurement, weekly measure, and one-year follow up is planned to be collected through an online survey.
Interventions
- Behavioral Internet-based psychodynamic therapy (IPDT)
The intervention is 9 week long with weekly modules that the participants work with while receiving weekly support from an assigned therapist.
Primary outcome measures
- Neuroticism scale of the Maples et al (2014) IPIP NEO PI 120 Item representation [Time frame: Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination.]
Secondary outcome measures (7)
- Eysenck Personality Questionnaire Revised - Shortform (EPQR-S) [Time frame: Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination.]
- Patient Health Questionnaire-9 [Time frame: Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination.]
- Generalized Anxiety Disorder-7 [Time frame: Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination.]
- Brunnsviken Brief Quality of life scale [Time frame: Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination.]
- Difficulties in Emotion Regulation Scale-16 [Time frame: Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination. Will be measured on a weekly basis during the 9 weeks of the intervention period.]
- Defense Mechanism Rating Scale - Self Report 30 [Time frame: Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination.]
- Patient Health Questionnaire - 4 [Time frame: Change between baseline, end of treatment after nine weeks. Will be measured on a weekly basis during the intervention.]
Eligibility criteria
Inclusion criteria
- Score 5 points or more on either the PHQ-9 or GAD-7
- 18 years or older
- Ability to speak, read and write in Swedish
- Have access to the internet and a smartphone, computer or other device
Exclusion criteria
- Severe psychiatric or somatic illness that makes participation difficult or impossible
- Ongoing addiction
- Acute suicidality
- Other ongoing psychological treatment
- Recent (within the latest month) changes in the dose of psychotropic medication or planned change of dose during the treatment weeks
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Sweden · 1 center
- Department of Behavioral Sciences and Learning — Linköping
Identifiers
NCT: NCT06665321 · LINNEA